mTOR activity in AIDS-related diffuse large B-cell lymphoma.
Patients infected with HIV have a significantly increased risk of developing non-Hodgkin lymphomas despite the widespread use of HAART. To investigate mTOR pathway activity in acquired immunodeficiency syndrome (AIDS) related diffuse large B-cell lymphoma AR-DLBCL, we used immunohistochemistry to ex...
Main Authors: | Sara H Browne, Julio A Diaz-Perez, Michael Preziosi, Charles C King, George A Jones, Sonia Jain, Xiaoying Sun, Erin G Reid, Scott VandenBerg, Huan-You Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5305194?pdf=render |
Similar Items
-
The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas
by: Pinelopi Argyriou, et al.
Published: (2012-01-01) -
miR‐155‐regulated mTOR and Toll‐like receptor 5 in gastric diffuse large B‐cell lymphoma
by: Wei‐Ting Huang, et al.
Published: (2022-02-01) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
by: Victor H. Villar, et al.
Published: (2017-05-01) -
Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01) -
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1.
by: Sharmila Mallya, et al.
Published: (2014-01-01)